Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Interleukin (IL)-17 is a recently described cytokine involved in the amplification of inflammatory responses and pathologies. A hallmark feature of IL-17 is its ability to induce expression of other cytokines and chemokines. In addition, IL-17 potently synergizes with tumor necrosis factor-alpha (TNFalpha) to up-regulate expression of many target genes, particularly IL-6. Despite the many observations of IL-17 signaling synergy observed to date, little is known about the molecular mechanisms that underlie this phenomenon. In the osteoblastic cell line MC-3T3, we have found that IL-17 and TNFalpha exhibit potent synergy in mediating IL-6 secretion. Here, we show that at least part of the functional cooperation between IL-17 and TNFalpha occurs at the level of IL-6 gene transcription. Both the NF-kappaB and CCAAT/enhancer-binding protein (C/EBP; NF-IL6) sites in the IL-6 promoter are important for cooperative gene expression, but NF-kappaB does not appear to be the direct target of the combined signal. Microarray analysis using the Affymetrix mouse MG-U74v2 chip identified C/EBPdelta as another gene target of combined IL-17- and TNFalpha-induced signaling. Because C/EBP family members are known to control IL-6, we examined whether enhanced C/EBPdelta expression is involved in the cooperative up-regulation of IL-6 by IL-17 and TNFalpha. Accordingly, we show that C/EBPdelta (or the related transcription factor C/EBPbeta) is essential for expression of IL-6. Moreover, overexpression of C/EBPdelta (and, to a lesser extent, C/EBPbeta) could substitute for the IL-17 signal at the level of IL-6 transcription. Thus, C/EBP family members, particularly C/EBPdelta, appear to be important for the functional cooperation between IL-17 and TNFalpha.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NF-κB subsequently upregulates expression of IκBζ and Bcl3, noncanonical members of the NF-κB family that in turn promote expression of various IL-17-NF-κB driven pro-inflammatory and anti-microbial genes”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“In addition to synergizing with strong NF-κB activators such as TNFα, lipopolysaccharide (LPS), IL-1β and lymphotoxin, IL-17 cooperates with IFNγ (activator of STAT1), IL-13 (STAT6), TGFβ (SMADs), fibroblast growth factor (FGF)2 (Ras:Raf) and a Candida albicans-derived pore-forming toxin from Candida albicans (c-Fos)”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One of the best-studied examples of synergy is with TNFα”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
In the citing paper
“One curious aspect of IL-17 biology is that this cytokine is consistently a modest activator of signaling in vitro, regardless of the cell system analyzed”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Ruddy et al., 2004
Citations
Cites
Tumor necrosis factor signaling
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401189 · Cited by 2,359
Aggarwal, S., Ghilardi, N., Xie, M.-H., de Sauvage, F. J., & Gurney, A. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207577200 · Cited by 1,847
Kotake, S., Udagawa, N., Takahashi, N., Matsuzaki, K., Itoh, K., Ishiyama, S., Saito, S., Inoue, K., Kamatani, N., Gillespie, M. T., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5703 · Cited by 1,696
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines
Fossiez, F., Djossou, O., Chomarat, P., Flores-Romo, L., Ait-Yahia, S., Maat, C., Pin, J. J., Garrone, P., Garcia, E., Saeland, S., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.6.2593 · Cited by 1,526
A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family.
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T., & Kishimoto, T. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08316.x · Cited by 1,482
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Andersson, S., Davis, D. L., Dahlbäck, H., Jörnvall, H., & Russell, D. W. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83172-6 · Cited by 1,229
Human IL-17: a novel cytokine derived from T cells
Yao, Z., Painter, S. L., Fanslow, W. C., Ulrich, D., Macduff, B. M., Spriggs, M. K., & Armitage, R. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.12.5483 · Cited by 1,021
Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994
Research works printed but not linked: 2
- Libermann, 1990, Mol. Cell. Biol., 10, 2327
- Andoh, 2002, Int. J. Mol. Med., 10, 631
Cited by
Items 201–300 of 365
Th17 and IL-17 immunity in chronic hepatitis C infection.
Balanescu, P. C., Lădaru, A., Voiosu, T. A., Nicolau, A., Ene, M., & Balanescu, A. (2012) · PubMed · Cited by 37
A bispecific antibody against IL-1β and IL-17A is beneficial for experimental rheumatoid arthritis
Qi, J., Kan, F., Ye, X., Guo, M., Zhang, Y., Ren, G., & Li, D. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2012.10.005 · Cited by 34
Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies
Yan, X.-Z., Lai, L., Ao, Q., Tian, X.-H., & Zhang, Y.-H. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210823110004 · Cited by 32
“C/EBP family members are part of the synergistic activation of IL-17A and TNF-α, and these alternative translations and phosphorylation of C/EBPβ are mediated by the IL-17RA CBAD domain, linking C/EBPβ to negative regulation of IL-17 [23].”
BackgroundThe Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment
Paroli, M., Spadea, L., Caccavale, R., Spadea, L., Paroli, M. P., & Nante, N. (2022) · Medicina · doi:10.3390/medicina58111552 · Cited by 39
Marzano, A. V., Tavecchio, S., Berti, E., Gelmetti, C. M., & Cugno, M. (2015) · Medicine · doi:10.1097/md.0000000000001818 · Cited by 30
Glenn, J. D., Liu, C., & Whartenby, K. A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4hi0818-335r · Cited by 38
Wu, H., Tsai, L., Huang, C.-K., Hsu, P., Chen, M., Chen, Y. M., Hu, C., Shen, C., Lee, C., Chang, M., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abc2823 · Cited by 34
“ACT1 also relies on its E3 ligase activity for downstream IL-17 signaling transduction, leading to the activation of the nuclear factor B (NF-B) and mitogen-activated protein kinase (MAPK) pathways, as well as the C/EBPs pathway (42, 43).”
BackgroundVitorino, T. R., do Prado, A. F., Cáu, S. B. D. A., & Rizzi, É. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115684 · Cited by 35
Qu, M., Song, N., Chai, G., Wu, X., & Liu, W. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.08.033 · Cited by 32
“Meanwhile, IL-6 seems to be a major signaling target of IL-17 in a variety of cells including macrophages, fibroblasts, osteoblasts, epithelial cells, and chondrocytes [67–72].”
BackgroundIL-17A synergistically enhances TNFα-induced IL-6 and CCL20 production in 3T3-L1 adipocytes
Shinjo, T., Iwashita, M., Yamashita, A., Sano, T., Tsuruta, M., Matsunaga, H., Sanui, T., Asano, T., & Nishimura, F. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.06.049 · Cited by 33
Genome-wide interaction study of dust mite allergen on lung function in children with asthma
Forno, E., Sordillo, J. E., Brehm, J. M., Chen, W., Benos, T., Yan, Q., Ávila, L., Soto-Quirós, M., Cloutier, M. M., Colón‐Semidey, A., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.12.967 · Cited by 29
“CEBPb is one of the mediators of IL-17A and IL-17F signaling pathways, as well as nuclear factor kappa B signaling.(37,38) CEBPb is also involved in IL-4, IL-6, and other signaling pathways (not shown).”
BackgroundShen, F., Verma, A. H., Volk, A. L., Jones, B. H., Coleman, B. M., Loza, M. J., Malaviya, R., Moore, B. A., Weinstock, D., Elloso, M. M., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801436 · Cited by 33
“One of the best-studied examples of synergy is with TNF-a (38, 43).”
BackgroundSelf-citationInterleukin-17: Functional and Structural Features, Application as a Therapeutic Target
Kostareva, O. S., Gabdulkhakov, A. G., Kolyadenko, I., Garber, M., & Tishchenko, S. (2019) · Biochemistry (Moscow) · doi:10.1134/s0006297919140116 · Cited by 36
Interleukin-17A Gene Expression in Morbidly Obese Women
Zapata-Gonzalez, F., Auguet, T., Aragonès, G., Guiu‐Jurado, E., Berlanga, A., Martínez, S., Martí, A., Sabench, F., Hernández, M., Aguilar, C., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817469 · Cited by 30
“It is also known that IL-6 is required for the differentiation of naive CD4 T cells into the Th17 lineage [39,40] and is a major downstream gene target of IL-17A [41,42].”
BackgroundZaķe, T., Skuja, S., Kalere, I., Konrāde, I., & Groma, V. (2018) · Medicine · doi:10.1097/md.0000000000011211 · Cited by 35
Bosteen, M. H., Tritsaris, K., Hansen, A. J., & Dissing, S. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1354-5 · Cited by 35
“In addition, the effect of activation of enhancer binding proteins (C/EBP) could be important as it has been shown in relation to IL-6 synthesis [40].”
Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
Gisondi, P., Vedove, C. D., & Girolomoni, G. (2014) · Dermatology and Therapy · doi:10.1007/s13555-014-0042-5 · Cited by 34
Tsai, V. W.-W., Mohammad, M. G., Tolhurst, O., Breit, S. N., Sawchenko, P. E., & Brown, D. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3449-11.2011 · Cited by 28
“Both TNF and IL-1 are potent proinflammatory cytokines, with the later involved in Th17 phenotype development (Ben-Sasson et al., 2009).”
CCAAT/enhancer binding protein delta in microglial activation
Ejarque‐Ortiz, A., Gresa‐Arribas, N., Straccia, M., Mancera, P., Solà, C., Tusell, J. M., Serratosa, J., & Saura, J. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22272 · Cited by 32
“A direct regulation by C/EBPd has been demonstrated for the expression of COX-2 in macrophages (Wadleigh et al., 2000), NO synthase-2 (NOS-2) in C6 cells and primary astroglial cultures (Won et al., 2003), IL-1b in macrophages (Godambe et al., 1994) or IL-6 in osteoblasts (Ruddy et al., 2004).”
BackgroundSønder, S. U., Paun, A., Ha, H.-L., Johnson, P. F., & Siebenlist, U. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103233 · Cited by 27
Noll, J., Helk, E., Fehling, H., Bernin, H., Marggraff, C., Jacobs, T., Huber, S., Pelczar, P., Ernst, T., Ittrich, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.013 · Cited by 29
Giunta, A., Ventura, A., Chimenti, M. S., Bianchi, L., & Esposito, M. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s92128 · Cited by 28
Manjunath, Y., Yoshida, T., Valente, A. J., Kandikattu, H. K., Sakamuri, S. S. V. P., Siddesha, J. M., Sukhanov, S., Saifudeen, Z. R., Ma, L., Siebenlist, U. K., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.724138 · Cited by 26
“Cardiac-restricted TRAF3IP2 Overexpression Results in IKK/ NF- B, JNK/AP-1, c/EBP , and p38 MAPK Activation— Because TRAF3IP2 is an upstream regulator of IKK/NF- B, JNK/AP-1, and c/EBP (11, 12, 19), we investigated whether TRAF3IP2 overexpression results in their spontaneous activation.”
BackgroundCytokine and Chemokine Profile in Amicrobial Pustulosis of the Folds
Marzano, A. V., Tavecchio, S., Berti, E., Gelmetti, C. M., & Cugno, M. (2015) · Medicine · doi:10.1097/md.0000000000002301 · Cited by 26
“IL-17 contributes to neutrophil and monocyte chemotaxis by stimulating the tissue production of chemokines(30) and acting in combination with other proinflammatory cytokines.(31) In addition, IL-17, synergizing with IL-1 and TNF-alpha, increases the production of MMP-2 and MMP-9.”
BackgroundFriedrich, M., Diegelmann, J., Beigel, F., & Brand, S. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000121 · Cited by 27
“The cooperation between IL-17A and TNF-a has formerly been shown for distinct target genes and several cell lines, such as osteoblasts.(9) In another study, a limited set of target chemokines induced in IEC by stimulation with IL-17A and TNF-a(28) was analyzed.”
BackgroundPerforin, COVID‐19 and a possible pathogenic auto‐inflammatory feedback loop
Cunningham, L., Kimber, I., Basketter, D. A., Simmonds, P., McSweeney, S. M., Tziotzios, C., & McFadden, J. P. (2021) · Scandinavian Journal of Immunology · doi:10.1111/sji.13102 · Cited by 29
IκBζ is an essential mediator of immunity to oropharyngeal candidiasis
Taylor, T. C., Coleman, B. M., Arunkumar, S. P., Dey, I., Dillon, J. T., Ponde, N. O., Poholek, A. C., Schwartz, D. M., McGeachy, M. J., Conti, H. R., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.08.016 · Cited by 24
Self-citationPotential Application of Probiotics in the Prevention and Treatment of Inflammatory Bowel Diseases
del Carmen, S., de LeBlanc, A. D. M., Miyoshi, A., Rocha, C. S., Azevedo, V., & LeBlanc, J. G. (2010) · Ulcers · doi:10.1155/2011/841651 · Cited by 31
“the lack of Treg cells or the excessive production of effector T cells participates in the development and exacerbation of IBD [59, 60].”
BackgroundDexmedetomidine mitigate acute lung injury by inhibiting IL-17-induced inflammatory reaction
Zhang, Y., Jia, S., Gao, T., Zhang, R., Liu, Z., & Wang, Y. (2017) · Immunobiology · doi:10.1016/j.imbio.2017.10.017 · Cited by 25
C/EBPβ Promotes Immunity to Oral Candidiasis through Regulation of β-Defensins
Simpson-Abelson, M. R., Childs, E. E., Ferreira, M. C., Bishu, S., Conti, H. R., & Gaffen, S. L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136538 · Cited by 24
“Considerable evidence supports a vital role for IL-17 in immunity to OPC [26], and IL-17 induces downstream signals in part through C/EBPβ [13, 14].”
BackgroundSelf-citationRamani, K., & Biswas, P. S. (2015) · Clinical Immunology · doi:10.1016/j.clim.2015.10.009 · Cited by 24
Gao, Q., LIU, Y., Wu, Y. R., Zhao, Q., Wang, L., Gao, S., WEN, W., Zhang, W., GUO, N., Zhou, J., et al. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2433 · Cited by 30
“89‐fold) and, as has also previously been shown, that IL-17 activated the NF-κB pathway (22).”
BackgroundInsights into the Pathogenesis of Pyoderma Gangrenosum
Becker, S., Vague, M., & Ortega‐Loayza, A. G. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.09.023 · Cited by 27
Gao, C., Koko, M. Y. F., Ding, M., Hong, W., Li, J., Dong, N., & Hui, M. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.927272 · Cited by 27
Dong, C., Kong, S., Zheng, X., Zhang, J., Nie, G., Li, X., & Xu, P. (2018) · Gene · doi:10.1016/j.gene.2018.10.038 · Cited by 24
Mechanisms and functions of IL-17 signaling in renal autoimmune diseases
Schmidt, T., Luebbe, J., Paust, H., & Panzer, U. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.09.005 · Cited by 24
“It has been well documented that IL-17 A and IL-17 F can induce proinflammatory gene expression, both alone and particularly in synergy with TNFα, IL-6, G-CSF, IL-1, CXCL1, CCL20, and matrix metalloproteases (Awane et al., 1999; Chen et al., 2003; Ruddy et al., 2004).”
BackgroundSun, Y., Li, J., Williams, M. T., Zamzow, M., Ran, H., Quinn, B., Aronow, B. J., Vorhees, C. V., Witte, D. P., & Grabowski, G. A. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-76 · Cited by 23
“Lipopolysaccharide (LPS) and galactosylsphingosine are exogenous ligands that regulate CEBPD expression in visceral tissues and astrocytes [27-31].”
BackgroundAltieri, A., Piyadasa, H., Recksiedler, B., Spicer, V., & Mookherjee, N. (2018) · Vaccines · doi:10.3390/vaccines6030051 · Cited by 22
“IL-17 is known to functionally–cooperate with TNF and amplify the responses induced by TNF primarily via the transcription factor CCAAT/enhancer-binding protein (C/EBP) [42].”
BackgroundNovel Analgesics with Peripheral Targets
Ciotu, C. I., & Fischer, M. J. M. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00937-z · Cited by 23
Basic biology and roles of CEBPD in cardiovascular disease
Li, T., Lin, S., Zhu, Y., Ye, D., Rong, X., & Wang, L. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02357-4 · Cited by 22
Contribution of Interleukin-17A to Retinal Degenerative Diseases
Zhong, H., & Sun, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.847937 · Cited by 25
de Mesquita, T. G. R., Santo, J. D. E., da Silva, L. D. O., Silva, G., de Araújo, F. J., Pinheiro, S. K., Kerr, H. K. A., da Silva, L. S., de Souza, L. M., de Almeida, S. A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.974051 · Cited by 22
“TNFa and IL1b induce the upregulation of IL-6 expression (57).”
BackgroundChen, X., Hashimoto, D., Ebata, K., Takahashi, S., Shimizu, Y., Shinozaki, R., Hasegawa, Y., Kikuchi, R., Senjo, H., Yoneda, K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211230119 · Cited by 22
Yang, Y., Chen, Y., Yu, L., Zhang, X., Shang, J., Fan, J., Zhang, R., Ren, J., & Duan, X. (2022) · Inflammation Research · doi:10.1007/s00011-022-01674-z · Cited by 21
“Moreover, TRAF6 promotes MAPK/AP1 pathway activation and transcription factors C/EBPβ and δ [34, 37, 38, 45] (see Fig.”
BackgroundToll-Like Receptors in Brain Abscess
Esen, N., & Kielian, T. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-00549-7_3 · Cited by 20
“Since IL-17 has been reported to synergize with other proinflammatory cytokines such as TNF- α and IL-1 β in various cell types (Chabaud et al. 2001 ; Maertzdorf et al. 2002 ; Ruddy et al. 2004b ; Dong 2008) , we examined whether this relationship would hold true for glia.”
Backgroundda Silva, T. A., Mariano, V. S., Sardinha-Silva, A., de Souza, M. A., Mineo, T. W. P., & Roque‐Barreira, M. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149721 · Cited by 19
“The inflammatory capacity of innate cells is enhanced by IL-17 [10] by recruiting additional inflammatory leukocytes, which eliminate microbial infections [11].”
BackgroundEvolutional perspective and functional characteristics of interleukin-17 in teleosts
Okamura, Y., Kono, T., Sakai, M., & Hikima, J.-I. (2022) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2022.108496 · Cited by 19
Interaction between Th17 and central nervous system in multiple sclerosis
Lai, S., Wu, X., Liu, Y., Liu, B., Wu, H., & Ma, K. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100928 · Cited by 20
“Evidence from both EAE and MS patients proves that IL-6 promoter can be activated by inflammatory cytokines like IL-1 β , TNF-α , TGF-β 1 and TGF-β 3 (Ruddy et al., 2004; Eickelberg et al., 1999; Mann et al., 2002).”
Chen, Y., Wang, S., Chen, X., Wu, Z., He, F., & Chen, Q. (2025) · Bone Research · doi:10.1038/s41413-025-00456-7 · Cited by 22
Ni, G., Liu, X., Li, H., Fogarty, C. E., Chen, S., Zhang, P., Liu, Y., Wu, X., Wei, M. Q., Chen, G., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.754770 · Cited by 19
Self-citationInterleukine-17-induced inhibitory effect on late stage murine erythroid bone marrow progenitors.
Bugarski, D. S., Krstić, J., Vlaski‐Lafarge, M., Petakov, M., Jovčić, G., Stojanovic, N., & Milenković, P. (2004) · PubMed · Cited by 20
Ren, Z., Li, M., Liu, R., Wang, Y., & Gu, H. (2014) · Biomarkers · doi:10.3109/1354750x.2014.924158 · Cited by 16
“IL17A plays an important role in inflammation and leads to the induction of many proinflammatory factors, including tumor necrosis factor-alpha (TNF-a), IL6 and IL1b (Ruddy et al., 2004).”
BackgroundIL-23 and Th17 cells in infections and psoriasis
Kagami, S. (2011) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.34.13 · Cited by 16
The RNA binding protein Arid5a drives IL-17–dependent autoantibody-induced glomerulonephritis
Li, Y., Vyas, S., Mehta, I. D., Asada, N., Dey, I., Taylor, T. C., Bechara, R., Amatya, N., Aggor, F. E. Y., Coleman, B. M., et al. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20240656 · Cited by 15
“…IL-17 integrates multiple inflammatory TFs to orchestrate downstream signaling and upregulates C/EBP β ( Cebpb ), C/EBP δ ( Cebpd ), and I κ B ζ ( Nfkbiz ) (Bechara et al., 2022; Johansen et al., 2015; Ruddy et al., 2004; Shen et al., 2006, 2009; Taylor et al., 2023; Willems et al., 2016).”
InfluentialSelf-citationGuo, X., Jiang, X., Xiao, Y., Zhou, T., Guo, Y., Wang, R., Zhao, Z. J., He, X., Hou, C., Ma, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089714 · Cited by 16
“In addition, the results of a microarray screen suggested the involvement of the CCAAT/enhancer binding protein transcription factors C/EBPb and C/EBPd in the IL-17A-induced signaling cascade [20], while another report showed that the PI3K pathway is involved in IL17A signaling, mainly in an Act1-independent manner [2…”
BackgroundHu, G., Zhang, N., Li, J., Wang, J., Wu, W., Li, J., Tong, W., Zhao, X., Dai, L., & Zhang, X. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.04.016 · Cited by 16
Decreased Absolute Number of Circulating Regulatory T Cells in Patients With Takayasu’s Arteritis
Jia, W., Fu, Z., Wang, X., Luo, J., Yan, C., Cao, J., YanLiu, Xie, J.-F., Liu, G., Gao, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.768244 · Cited by 15
“IL-17 is a strong inflammatory factor, that can activate T cells and stimulate endothelial cells, epithelial cells, and fibroblasts to induce inflammation in TA, and IL-17 also has a synergistic effect with TNF-a, and upregulates IL-6 expression to jointly regulate the inflammatory response (21).”
BackgroundThe role of immunity in insulin resistance in patients with polycystic ovary syndrome
Zhang, Q., Yang, Z., Ou, X., Zhang, M., Qin, X., & Wu, G. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1464561 · Cited by 22
Wu, D., Wang, S., Shen, M., Wang, Y., Zhang, B., Wu, Z., Lu, J., & Zheng, Y. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13532 · Cited by 14
“IL-17 is characterized by its ability to induce the expression of both cytokines and chemokines and has been reported to participate in the amplification of inflammatory responses.(34) The significant effects of IL-17 blockade have proved to be controversial, due to its weak functions in vitro, as on the one hand IL-6…”
BackgroundRetractedYang, Z., Wang, T., Wang, B., Gao, H., He, C., Shang, H., Lü, X., Wang, Y., & Xu, J. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00311-0 · Cited by 15
“We give specific introduction to recent findings of MCP‑1, IL‑6, TNF‑β and IL‑10 in hypertension and show under‑ lying effect in the pathogenesis of effects on kidney, cardiovascular and other tissues.”
BackgroundInfluentialAlmeida, R. D. S., Ramos, A. M. D. L., Luna, C. F., Pedrosa, F. D. P. R., Donadi, E. A., & Lucena‐Silva, N. (2017) · Cytokine · doi:10.1016/j.cyto.2017.07.014 · Cited by 14
Angiotensin II-induced Hypertension is Reduced by Deficiency of P-selectin Glycoprotein Ligand-1
Wang, Q., Wang, H., Wang, J., Venugopal, J., Kleiman, K., Guo, C., Sun, Y., & Eitzman, D. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-21588-3 · Cited by 14
Unveiling the role of IL-17: Therapeutic insights and cardiovascular implications
Jiang, K., Xu, Y., Wang, Y., Yin, N., Huang, F., & Chen, M. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.05.001 · Cited by 14
Qi, Y., Zheng, H., Liu, N., Guo, T., Zhu, W., Wang, S., Cui, B., & Ning, G. (2015) · Clinical Endocrinology · doi:10.1111/cen.12725 · Cited by 13
Hofstetter, H. H., Kovalovsky, A., Shive, C. L., Lehmann, P., & Forsthuber, T. G. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.04.001 · Cited by 13
“For example, IL-17 could promote autoimmune pathology by collaborating with TNF-α to induce IL-6 (Ruddy et al., 2004), a cytokine that has been shown to be critical in the pathogenesis of EAE (Eugster et al.”
BackgroundInterleukin-Mediated Pendrin Transcriptional Regulation in Airway and Esophageal Epithelia
Vanoni, S., Scantamburlo, G., Dossena, S., Paulmichl, M., & Nofziger, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030731 · Cited by 13
A Truncated IL‐17RC Peptide Ameliorates Synovitis and Bone Destruction of Arthritic Mice
Du, Y., Tong, Y., Mei, W., Jia, J., Niu, M., Cao, W., Lou, W., Li, S., Li, Z., Stinson, W. A., et al. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600668 · Cited by 13
Chaitidis, N., Papadopoulou, Z., Varvara, S. T., Panagiotidis, M., Katsigianni, I., & Sakellariou, G. T. (2024) · Rheumatology International · doi:10.1007/s00296-024-05647-9 · Cited by 12
IL-17RA in Intestinal Inflammation: Structure, Signaling, Function, and Clinical Application
Liu, S., Ren, J., & Li, J. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000217 · Cited by 14
“C/EBP Pathway CCAAT/enhancer-binding protein (C/EBP) family contains 6 members, among which C/EBPb and C/EBPd are targets of IL-17RA signaling.(13) C/EBPb and C/EBPd are critical for IL-6 transcription(52) but are regulated differently by IL-17RA (Fig.”
BackgroundMethodCytokine polymorphisms are associated with daytime napping in adults living with HIV
Byun, E., Gay, C., Portillo, C. J., Pullinger, C. R., Aouizerat, B. E., & Lee, K. A. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2016.12.021 · Cited by 12
“IL-17 is an important proinflammatory cytokine involved in the expression of many other proinflammatory cytokines, including IL-1b, IL-6, and TNFa, chemokines and mediators of tissue destruction in different cell types [53,54].”
BackgroundLipovsky, A. I., Slivka, P. F., Su, Z., Wang, Y., Paulsboe, S. E., Wetter, J. B., Namovic, M. T., Gauvin, D. M., Perron, D. C., Gauld, S. B., et al. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.10.029 · Cited by 13
Li, D., Bechara, R., Ramani, K., Jawale, C. V., Li, Y., Kolls, J. K., Gaffen, S. L., & Biswas, P. S. (2021) · JCI Insight · doi:10.1172/jci.insight.147505 · Cited by 12
“We also performed stimulations in conjunction with TNF-α , since IL-17 and TNF-α often signal in a potently synergistic manner (45).”
Self-citationFabricius, R. A., Sørensen, C. B., Skov, L., & Debes, N. M. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.893815 · Cited by 13
“IL-17 has been reported to synergize with other proinflammatory cytokines, such as TNF-α, and potentiate their effects (44, 45).”
BackgroundChen, C., Zhang, Q., Liu, S., Lambrechts, M., Qu, Y., & You, Z. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00343 · Cited by 13
“One of the substrates, CAAT enhancer binding protein β (C/EBPβ), is also induced by IL-17 (3, 9, 18).”
BackgroundIncreased Act1/IL-17R expression in Hirschsprung’s disease
Tomuschat, C., O’Donnell, A. M., Coyle, D., & Puri, P. (2016) · Pediatric Surgery International · doi:10.1007/s00383-016-3980-4 · Cited by 11
T cell transgressions: Tales of T cell form and function in diverse disease states
Harris, K. M., Clements, M. A., Kwilasz, A. J., & Watkins, L. R. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1921764 · Cited by 12
“CCAAT-enhancer-binding protein pathway [143,144].”
Suri, C., Awasthi, A., & Asthana, S. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.11.022 · Cited by 10
Wankhede, A. N., & Dhadse, P. (2022) · Journal of Indian Society of Periodontology · doi:10.4103/jisp.jisp_47_21 · Cited by 15
Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates
Nong, Y., Han, G., & Hawkes, J. E. (2024) · Cutis · doi:10.12788/cutis.0949 · Cited by 10
“37,38 C This also increases the expression of other keratinocyte-derived proteins (eg, human β -defensins, S-100 proteins, LL-37, other antimicrobial peptides, IL-19, IL-36, IL-17C) that act as reinforcing proinflammatory signals or chemotactic factors ( 39-41 Routine immunohistochemical staining…”
BackgroundDeepak, P., & Acharya, A. (2010) · International Reviews of Immunology · doi:10.3109/08830185.2010.483027 · Cited by 10
Ma, S., Zhang, S., Ren, X., Feng, Y., Li, H., Chen, S., Xu, J.-G., Wang, Y., Peng, G.-Y., Yan, Q., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1434127 · Cited by 9
TGF-Β as a Marker of Ulcerative Colitis and Disease Severity
Jovanović, M., Zdravković, N., Jovanović, I., Radosavljevic, G. D., Gajović, N., Zdravkovic, N. D., Marić, V., & Arsenijević, N. (2018) · Serbian Journal of Experimental and Clinical Research · doi:10.1515/sjecr-2017-0019 · Cited by 9
Positive-Negative Feedback Loop between Mir-197 and IL-17A Signaling in Human Keratinocytes
Elharrar, E., & Masalha, M. (2016) · Immunome Research · doi:10.4172/1745-7580.10000111 · Cited by 9
“The signaling that IL-17A, IL-17F and IL-17E activate are transcribed via one of three transcriptions factors; NFkB, C/EBP or AP1[18-20].”
BackgroundChen, P., Li, Y., Li, L., Zhang, G., Zhang, F., Tang, Y., Zhou, L. Q., Yang, Y., & Li, J. (2021) · Journal of International Medical Research · doi:10.1177/03000605211053233 · Cited by 11
Engineering Lactic Acid Bacteria and Bifidobacteria for Mucosal Delivery of Health Molecules
Allain, T., Aubry, C., Natividad, J. M., Chatel, J., Langella, P., & Bermúdez‐Humarán, L. G. (2015) · Wiley eBooks · doi:10.1002/9781118868386.ch11 · Cited by 9
Regulation of Interleukin-17 Production
Dong, W., & Ma, X. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_7 · Cited by 7
Huppler, A. R., Whibley, N., Woolford, C. A., Childs, E. E., He, J., Biswas, P. S., McGeachy, M. J., Mitchell, A. P., & Gaffen, S. L. (2015) · Infection and Immunity · doi:10.1128/iai.03057-14 · Cited by 9
“However, conditioned medium from DAY286-IL17A cells (diluted 1:10 to a concentration of 6 to 8 ng/ml of IL-17A) induced marked secretion of both IL-6 (Fig.”
BackgroundInfluentialSelf-citationXu, M., Tan, C., Zhou, J., Huang, X., Dai, Z., Zhu, H., Zhao, Y., Gu, F., Zhou, S., & Fan, J. (2009) · Transplant Immunology · doi:10.1016/j.trim.2009.11.003 · Cited by 7
Integrating p38α MAPK immune signals in nonimmune cells
Gaffen, S. L., & McGeachy, M. J. (2015) · Science Signaling · doi:10.1126/scisignal.aaa8398 · Cited by 9
“Because the effect of p38α seems to be independent of mRNA stability, which transcription factors are the targets of p38α? The activator protein (AP1) complex is likely to be a target, although the AP1-binding site is dispensable for IL-17–dependent activation of the proximal promoter of at least one relevant target g…”
BackgroundSelf-citationZheutlin, A. R., & Schiopu, E. (2018) · Case Reports in Rheumatology · doi:10.1155/2018/6760806 · Cited by 7
“IL-17A and TNF have been suggested as synergistic inflammatory factors [20].”
BackgroundIMAIZUMI, N., Gondaira, S., KAMIOKA, M., Sugiura, T., Eguchi, A., NISHI, K., Fujiki, J., Iwano, H., & Higuchi, H. (2024) · Journal of Veterinary Medical Science · doi:10.1292/jvms.24-0097 · Cited by 6
“According to reports, IL-17 induces the production of cytokines (IL-1β, IL-6, TNF-α) and the chemokine (RANTES) to boost immune responses, and it also synergises with other cytokines like TNF-α and IFN-γ [23].”
C/EBPδ Mediates Immunity to Renal Autoinflammatory Disorders in a Stage-specific Manner
Dey, I., Li, Y., Taylor, T. C., Peroumal, D., Asada, N., Panzer, U., Biswas, P. S., Sterneck, E., & Gaffen, S. L. (2024) · The Journal of Immunology · doi:10.4049/jimmunol.2400124 · Cited by 6
Self-citationda Silva, L. S., Santo, J. D. E., de Mesquita, T. G. R., Santos, V. A. M., de Souza, J. L., de Araújo, F. J., Júnior, C. M. D. S., da Silva, C. C., Queiroz, K. L. G. D., Sequera, H. D. G., et al. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab320 · Cited by 11
Yang, J., Kou, J., Lim, J.-E., Lalonde, R., & Fukuchi, K.-I. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.11.005 · Cited by 6
Contie, M., Léger, O. J. P., Fouque, N., Poitevin, Y., Kosco‐Vilbois, M. H., Mermod, N., & Elson, G. (2012) · Biotechnology and Bioengineering · doi:10.1002/bit.24763 · Cited by 7
“Recombinant IL-17F was produced and its biological activity confirmed using a functional cellbased assay (Ruddy et al., 2004; data not shown).”
MethodThe Effect of HIV and Art on the Development of Hypertension and Type 2 Diabetes Mellitus
Maseko, T., & Masuku, S. (2017) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000732 · Cited by 8
Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis
Hong, L., Herjan, T., Chen, X., Zagore, L. L., Bulek, K., Wang, H., Yang, C. J., Licatalosi, D. D., Li, X., & Li, X. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20231442 · Cited by 5
“…of NF-κ B [Chang et al., 2006; Garg et al., 2013; Qian et al., 2007; Sønder et al., 2011; Zhong et al., 2012] and C/EBP [Maitra et al., 2007; Ruddy et al., 2004; Shen et al., 2006, 2009; Sønder et al., 2012]) and less well-defined, but more robust posttranscriptional changes that include…”
Liu, T., Mao, T., Fan, J., Shen, Y., Xue, L., Du, K., Yang, L., Wang, L., & Wang, X. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70546 · Cited by 5
Winton, H. L., Bidwell, J. L., & Armitage, W. J. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2014.04.003 · Cited by 5
“IL-17 potently synergizes with TNF-a to up-regulate expression of many target genes, and at least part of the functional cooperation between IL-17 and TNF-a occurs at the level of IL-6 gene transcription [54].”
BackgroundIdentification of miRnas with possible prognostic roles for HAM/TSP
de Souza, D. R. V., Pessôa, R., Nukui, Y., Pereira, J. P., Marcusso, R. M. N., de Oliveira, A. C. P., Casseb, J., Duarte, A. J. D. S., Clissa, P. B., & Sanabani, S. S. (2023) · Virulence · doi:10.1080/21505594.2023.2230015 · Cited by 7
“Consequently, cellular senescence, an irreversible state of cell cycle arrest, is a molecular signalling pathway possibly associated with HAM/TSP. Merling and colleagues [60] had previously proposed that Tax protein triggers cellular senescence by a mechanism other than IKK/NF-B activation.”
ResultInfluential
Metadata
- Authors
- Ruddy, M. J., Wong, G. C., Liu, X. K., Yamamoto, H., Kasayama, S., Kirkwood, K. L., & Gaffen, S. L.
- Affiliations
- University at Buffalo, State University of New York (US)
- The University of Osaka (JP)
- Corresponding author
- Gaffen, Sarah L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 279
- Issue
- 4
- Pages
- 2559-2567
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087851913
- Cited by
- 364
- References
- 54
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 15 · 2023: 10 · 2022: 20 · 2021: 24 · 2020: 14 · 2019: 15 · 2018: 19 · 2017: 21 · 2016: 14 · 2015: 20 · 2014: 22 · 2013: 13 · 2012: 18
- FWCI
- 6.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6134 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI49329, AI 07614, T32AI007614)
- National Institute of Dental and Craniofacial Research (DE14460, R03DE014460)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- IL-17, TNF-α, C/EBP family, C/EBPδ, C/EBPβ, cytokine synergy, NF-κB, IL-6 promoter, transcriptional regulation
- MeSH terms
- Animals, Cell Line, Drug Synergism, Osteoblasts, Tumor Necrosis Factor-alpha, Signal Transduction, Transcriptional Activation, Interleukin-6, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.